The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Regulatory News (ASHM)

Share Price Information for Ashmore (ASHM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 196.30
Bid: 195.80
Ask: 196.10
Change: 0.90 (0.46%)
Spread: 0.30 (0.153%)
Open: 198.70
High: 198.70
Low: 195.80
Prev. Close: 196.30
ASHM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

End of Stabilisation

24 Oct 2006 07:02

Ashmore Group PLC24 October 2006 These written materials are not for distribution (directly or indirectly) in orto the United States, Canada, Australia or Japan. They are not an offer ofsecurities for sale in or into the United States, Canada, Australia or Japan. The Shares of the Company are not being registered under the US Securities Actof 1933, as amended (the 'Securities Act') and may not be offered or sold in theUnited States unless registered under the Securities Act or pursuant to anexemption from such registration. No money, securities or other considerationis being solicited and, if sent in response to the information contained herein,will not be accepted. 24 October 2006 Ashmore Group plc ('Ashmore' or the 'Company') Announcement of Utilisation of Over-allotment Option: Ashmore Group plc In connection with the Placing in relation to the following ordinary shares: Ashmore Group plc ordinary shares of 0.01p eachISIN Code: GB00B132NW22 Ashmore announces that, in connection with the Placing of 177,266,000 ordinaryshares by Ashmore, UBS Limited, as stabilising manager, has given notice toutilise the Over-allotment Option in full in respect of 17,726,600 ordinaryshares in Ashmore. None of the £30.1 million gross proceeds arising from theutilisation of the Over-allotment Option will be received by Ashmore. Including the utilisation of the Over-allotment Option, the total size of thePlacing is 194,992,600 ordinary shares. Following the utilisation of theOver-allotment Option and as a consequence of the Over-allotment Arrangements,Mark Coombs will be beneficially interested in 303,324,200 Ashmore ordinaryshares and Jon Moulton will be beneficially interested in 30,511,700 Ashmoreordinary shares. The Placing Price of Ashmore ordinary shares of 0.01p each was set at 170p perordinary share on 12 October 2006. UBS Limited, as stabilising manager has also informed the Company that thestabilisation period which commenced at 8am on 12 October 2006 has now ended andthat it made no stabilisation trades. Further details in respect of the Over-allotment Option and the Over-allotmentArrangements are set out in Ashmore's Prospectus dated 12 October 2006. Defined terms used in this announcement have the same meaning as in theCompany's Prospectus dated 12 October 2006 unless the context requiresotherwise. This announcement may not be distributed, directly or indirectly, in or into theUnited States, Canada, Australia or Japan. This announcement is for information purposes only and does not constitute aninvitation or offer to underwrite, subscribe for or otherwise acquire or disposeof any securities of Ashmore Group plc in any jurisdiction. In addition, if and to the extent that this announcement is communicated in, orthe offer of the securities to which it relates is made in, any EEA Member Statethat has implemented Directive 2003/71/EC (together with any applicableimplementing measures in any Member State, the 'Prospectus Directive') beforethe publication of a prospectus in relation to the securities which has beenapproved by the competent authority in that Member State in accordance with theProspectus Directive (or which has been approved by a competent authority inanother Member State and notified to the competent authority in that MemberState in accordance with the Prospectus Directive), this announcement and thePlacing are only addressed to and directed at persons in that Member State whoare qualified investors within the meaning of the Prospectus Directive (or whoare other persons to whom the offer may lawfully be addressed) and must not beacted on or relied on by other persons in that Member State. The Placing and the distribution of this announcement and other information inconnection with the Placing in certain jurisdictions may be restricted by lawand persons into whose possession any document or other information referred toherein comes should inform themselves about and observe any such restriction.Any failure to comply with these restrictions may constitute a violation of thesecurities laws of any such jurisdiction. This announcement is not an offer of securities for sale into the United States.The securities have not been, and will not be, registered under the U.S.Securities Act of 1933 and may not be offered or sold in the United Statesabsent registration or an exemption from registration. There will be no publicoffer of securities in the United States. Stabilisation/FSA END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st May 20243:01 pmRNSDirectorate Change
1st May 202411:11 amRNSDirector/PDMR Shareholding
18th Apr 20241:11 pmRNSDirectorate Change
15th Apr 20247:00 amRNSTrading Statement
18th Mar 20243:30 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:30 amRNSHolding(s) in Company
11th Dec 202311:21 amRNSDirector/PDMR Shareholding
18th Oct 20232:13 pmRNSResult of AGM
13th Oct 20237:00 amRNSTrading Statement
19th Sep 202311:00 amRNSDirector/PDMR Shareholding
19th Sep 202310:08 amRNSHolding(s) in Company
15th Sep 20235:06 pmRNSHolding(s) in Company
14th Sep 20232:56 pmRNSNotice of AGM
14th Sep 202310:29 amRNSDirector/PDMR Shareholding
6th Sep 20237:00 amRNSFinal Results
14th Jul 20231:51 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSTrading Statement
11th Jul 20232:10 pmRNSHolding(s) in Company
10th Jul 20232:48 pmRNSHolding(s) in Company
30th Jun 20235:11 pmRNSHolding(s) in Company
29th Jun 20239:09 amRNSHolding(s) in Company
14th Jun 20239:23 amRNSHolding(s) in Company
19th May 20238:35 amRNSDirector Declaration
21st Apr 20237:00 amRNSDirectorate Change
17th Apr 20237:00 amRNSTrading Statement
14th Apr 20239:30 amRNSAGM Statement
31st Mar 20232:33 pmRNSDirector/PDMR Shareholding
17th Mar 202310:21 amRNSDirector/PDMR Shareholding
13th Mar 202310:23 amRNSAudit tender process
8th Mar 20239:48 amRNSHolding(s) in Company
27th Feb 20239:41 amRNSHolding(s) in Company
16th Feb 20234:53 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:02 pmRNSHolding(s) in Company
25th Jan 20233:25 pmRNSHolding(s) in Company
24th Jan 20236:12 pmRNSHolding(s) in Company
23rd Jan 20239:01 amRNSHolding(s) in Company
19th Jan 20234:55 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSTrading Statement
12th Jan 20233:26 pmRNSHolding(s) in Company
11th Jan 20234:27 pmRNSHolding(s) in Company
9th Jan 20233:13 pmRNSHolding(s) in Company
5th Jan 20235:14 pmRNSHolding(s) in Company
16th Dec 20223:52 pmRNSHolding(s) in Company
8th Nov 20224:20 pmRNSHolding(s) in Company
28th Oct 202210:13 amRNSHolding(s) in Company
14th Oct 20222:11 pmRNSResult of AGM
14th Oct 20227:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.